Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
L. H. Schmidt, A. Kuemmel, M. Schuler, S. Biesterfeld, A. Faldum, M. Sebastian, C. Taube, R. Buhl, R. Wiewrodt (Mainz, Essen, Germany). Bcl-2, Bcl-xl, and pp32/PHAPI in resected non-small-cell lung cancer patients. Eur Respir J 2008; 32: Suppl. 52, 2603

Member's Comments

No comment yet.

Related content which might interest you: Expression of Her-2/neu and Bcl-2 in patients with non-small cell lung cancer Source: International Congress 2017 – Gene signatures in bronchial diseases Year: 2017 Expression of p53, Bcl-2 and Bax in non-small cell lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 512s Year: 2007 Survivin expression in non-small cell lung cancer Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Prognostic significance of p53 and bcl-2 abnormalities in operable non-small cell lung cancer Source: Eur Respir J 2001; 17: 660-666 Year: 2001 ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer Year: 2009 Role of EBUS-TBNA in the study of PD-L1 expression in patients with non-small cell lung cancer (NSCLC) Source: Virtual Congress 2020 – Endobronchial ultrasound: from rookie to pro Year: 2020 TNFα as a prognostic factor in surgically treated non-small cell lung carcinomas Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005 p-53 and HER2/neu expression in relation to chemotherapy response in patients with non-small cell lung cancer Source: Annual Congress 2007 - Novel genetic markers in pathology Year: 2007 Lung cancer Source: Respipedia Article Year: 2018 Combined expression of p53, Bcl-2 and p21WAF-1 proteins in endobronchial biopsies may be associated with lung cancer prognosis Source: Eur Respir J 2001; 18: Suppl. 33, 230s Year: 2001 The positive prognostic impact of Bcl-xl and Bcl-2 in chemo-naive lung cancer patients depends on stage and histology Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010 HER-2/neu oncoprotein expression in nonsmall cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 230s Year: 2002 MDM-2 gene amplification is associated with poor prognosis in operable non-small cell lung cancer (NSCLC) Source: Eur Respir J 2002; 20: Suppl. 38, 596s Year: 2002 p53 and mdm2 expression in nonsmall cell lung cancer (NSCLC): the lack of prognostic relevance Source: Eur Respir J 2001; 18: Suppl. 33, 230s Year: 2001 Bcl-2 as a prognostic factor for survival in small-cell lung cancer Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009 Investigation of survivin gene polymorphism in non-small cell lung cancer patients (NSCLC) Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Her/2 neu and p53 expression in patients with non-small cell lung cancer predict shortened survival Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications Source: Eur Respir J 2009; 33: 127-133 Year: 2009 Adenovirus-mediated E2F-1 gene transfer in nonsmall-cell lung cancer induces cell growth arrest and apoptosis Source: Eur Respir J 2002; 20: 703-709 Year: 2002 The expression of Bcl-xl correlates with improved survival in chemo-naive, surgically resected NSCLC patients Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology Year: 2007